UK Markets closed

Newron Pharmaceuticals S.p.A. (NWPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.80000.0000 (0.00%)
At close: 10:28AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.8000
Open2.7900
Bid0.0000 x 0
Ask0.0000 x 0
Day's range2.8000 - 2.8000
52-week range1.9629 - 3.0000
Volume2,000
Avg. volume0
Market cap49.967M
Beta (5Y monthly)0.96
PE ratio (TTM)N/A
EPS (TTM)-1.4050
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Newron Receives Fifth Tranche from Financing Agreement with European Investment Bank (EIB)

    Newron Pharmaceuticals SpA / Key word(s): Financing18-Oct-2021 / 17:45 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 SIX Listing RulesMilan, Italy - October 18, 2021, 5:45 pm CEST - Newron Pharmaceuticals S.p.A. ('Newron') (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peri

  • Business Wire

    Newron Announces Half-Year 2021 Results

    MILAN, September 16, 2021--Newron Pharmaceuticals S.p.A. (SIX: NWRN, XETRA: NP5) today announces its operational and financial results for the half-year ended June 30, 2021.

  • EQS Group

    Newron Receives Fourth Tranche from Financing Agreement with European Investment Bank (EIB)

    Newron Pharmaceuticals SpA / Key word(s): Financing06-Sep-2021 / 17:46 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 SIX Listing RulesMilan, Italy - September 6, 2021, 5.45 pm CEST - Newron Pharmaceutical S.p.A. ('Newron') (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peri